Related references
Note: Only part of the references are listed.Humanized Radioiodinated Minibody For Imaging of Prostate Stem Cell Antigen-Expressing Tumors
Jeffrey V. Leyton et al.
CLINICAL CANCER RESEARCH (2008)
Anaphylaxis after administration of ibritumomab tiuxetan for follicular non-Hodgkin lymphoma
Rachel Jankowitz et al.
CLINICAL NUCLEAR MEDICINE (2008)
PAW-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma
David V. Gold et al.
CLINICAL CANCER RESEARCH (2007)
MUC1/X protein immunization enhances cDNA immunization in generating Anti-MUC1 α/β junction antibodies that target malignant cells
Daniel B. Rubinstein et al.
CANCER RESEARCH (2006)
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients
Jan Wierecky et al.
CANCER RESEARCH (2006)
Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1
LM Pericleous et al.
BRITISH JOURNAL OF CANCER (2005)
Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles
K Engelmann et al.
GLYCOBIOLOGY (2005)
Vaccination with BLP25 lipsome vaccine to treat non-small cell lung and prostate cancers
Scott North et al.
EXPERT REVIEW OF VACCINES (2005)
A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently
XB Wang et al.
JOURNAL OF BIOCHEMISTRY (2004)
Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer
JYC Wong et al.
CLINICAL CANCER RESEARCH (2004)
Mucins in cancer: Protection and control of the cell surface
MA Hollingsworth et al.
NATURE REVIEWS CANCER (2004)
Increased expression of MUC1 in advanced pancreatic cancer
Y Hinoda et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Quantitative account of the enhanced affinity of two linked scFvs specific for different epitopes on the same antigen
HX Zhou
JOURNAL OF MOLECULAR BIOLOGY (2003)
Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: Its relationship with tumor progression and prognosis
S Tamada et al.
PATHOLOGY INTERNATIONAL (2002)
A human immunoglobulin G1 antibody originating from an in vitro-selected Fab phage antibody binds avidly to tumor-associated MUC1 and is efficiently internalized
P Henderikx et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Increasing the affinity for tumor antigen enhances bispecific antibody cytotoxicity
AM McCall et al.
JOURNAL OF IMMUNOLOGY (2001)
Fab chains as an efficient heterodimerization scaffold for the production of recombinant bispecific and trispecific antibody derivatives
R Schoonjans et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
